S Sadegh-Nasseri1, L J Stern, D C Wiley
1Laboratory of Immunology, NIAID, National Institutes of Health, Bethesda, Maryland 20892.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Major histocompatibility complex class II (MHC II) molecules exhibit distinct peptide binding kinetics, forming both transient and stable complexes. Peptide binding unexpectedly protects MHC II from denaturation, influencing its cellular behavior.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: